These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
39 related articles for article (PubMed ID: 16649442)
1. Primary Pediatric Hypertension: Current Understanding and Emerging Concepts. Tiu AC; Bishop MD; Asico LD; Jose PA; Villar VAM Curr Hypertens Rep; 2017 Sep; 19(9):70. PubMed ID: 28780627 [TBL] [Abstract][Full Text] [Related]
2. Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis. Ruano M; Silvestre V; Castro R; García-Lescún MC; Rodríguez A; Marco A; García-Blanch G Obes Surg; 2005 May; 15(5):670-6. PubMed ID: 15946459 [TBL] [Abstract][Full Text] [Related]
3. [Differential aspects of the dynamics of the renin-angiotensin-aldosterone system in obesity with and without hypertension and in essential arterial hypertension]. Cugini P; Salandi E; Menna P; Scavo D Quad Sclavo Diagn; 1983 Mar; 19(1):62-72. PubMed ID: 6371885 [TBL] [Abstract][Full Text] [Related]
4. Moderate weight loss reduces renin and aldosterone but does not influence basal or stimulated pituitary-adrenal axis function. Ho JT; Keogh JB; Bornstein SR; Ehrhart-Bornstein M; Lewis JG; Clifton PM; Torpy DJ Horm Metab Res; 2007 Sep; 39(9):694-9. PubMed ID: 17846979 [TBL] [Abstract][Full Text] [Related]
5. Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity. Gilardini L; Parati G; Sartorio A; Mazzilli G; Pontiggia B; Invitti C J Hum Hypertens; 2008 Feb; 22(2):75-82. PubMed ID: 17882228 [TBL] [Abstract][Full Text] [Related]
6. [The renin-angiotensin-aldosterone system in obesity associated with essential arterial hypertension]. Cugini P; Letizia C; Lucia P; Murano G; Massimiani F; Scavo D Recenti Prog Med; 1987 Apr; 78(4):140-3. PubMed ID: 3306843 [No Abstract] [Full Text] [Related]
7. [Blood pressure elevation in obese descendants of parents with essential arterial hypertension and its relation to the renin-angiotensin axis, C-reactive protein, and saline taste sensitivity]. Díaz JJ; Málaga I; Argüelles J; Díaz F Nefrologia; 2006; 26(1):148-50. PubMed ID: 16649442 [No Abstract] [Full Text] [Related]
9. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321 [TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid-stimulating activity of adipose tissue. Lamounier-Zepter V; Ehrhart-Bornstein M; Bornstein SR Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):567-75. PubMed ID: 16311217 [TBL] [Abstract][Full Text] [Related]
11. Hypertension and diabetes: role of the renin-angiotensin system. Jandeleit-Dahm K; Cooper ME Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581 [TBL] [Abstract][Full Text] [Related]
12. [Relation between the renin-angiotensin and kallikrein-kinin systems in the blood of hypertensive patients]. Zanozdra NS; Gomazkov OA; Svishchenko EP; Iakovlev AA; Chernoguz LS Vrach Delo; 1983 Oct; (10):24-7. PubMed ID: 6316667 [No Abstract] [Full Text] [Related]